Hyperprolactinaemia during famotidine therapy

Lancet. 1993 Oct 2;342(8875):868. doi: 10.1016/0140-6736(93)92729-d.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Breast / drug effects
  • Famotidine / adverse effects*
  • Famotidine / therapeutic use
  • Female
  • Humans
  • Hyperprolactinemia / chemically induced*

Substances

  • Famotidine